Posted by Michael Wonder on 09 Feb 2020
Extreme regulations to lower drug prices mean Canada will get fewer new drugs
7 February 2020 - Severe price cuts would clearly discourage pharmaceutical manufacturers from launching new drugs in Canada.
Ottawa has doubled down on the fantasy that government can legislate lower drug prices without causing unintended consequences.
The federal government is expanding the regulatory powers of the Patented Medicine Prices Review Board. The final public consultation on the guidelines for implementing the amended regulations closes 14 February. Barring a last-minute policy reversal, the new price-control regime will go into effect July 1.
